Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine-and 1, 2, 3, 4-tetrahydroisoquinoline-based arylsulfonamides

ES Vermeulen, M van Smeden…

Index: Journal of medicinal chemistry, , vol. 47, # 22 p. 5451 - 5466

Full Text: HTML

Citation Number: 53

Abstract

... Journal of Medicinal Chemistry. ... Department of Medicinal Chemistry, Center for Pharmacy, State University of ... J. Med. Chem. , 2004, 47 (22), pp 5451–5466. DOI: 10.1021/jm049743b. Publication Date (Web): September 23, 2004. Copyright © 2004 American Chemical Society. ...

Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine-and 1, 2, 3, 4-tetrahydroisoquinoline-based arylsulfonamides

[Vermeulen, Erik S; van Smeden, Marjan; Schmidt, Anne W; Sprouse, Jeffrey S; Wikstroem, Hakan V; Grol, Cor J Journal of medicinal chemistry, 2004 , vol. 47, # 22 p. 5451 - 5466]

Synthesis of substituted 4-(3-alkyl-1, 2, 4-oxadiazol-5-ylmethyl)-3, 4-dihydro-2H-1, 4-benzoxazines and 4-(1H-benzimidazol-2-ylmethyl)-3, 4-dihydro-2H-1, 4- …

[Tetrahedron Letters, , vol. 47, # 44 p. 7823 - 7826]

Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine-and 1, 2, 3, 4-tetrahydroisoquinoline-based arylsulfonamides

Abstract

Related Articles:

More Articles...